Monday, September 20, 2021
- Advertisement -spot_img



Telangana focuses on lifesaving drugs for Covid management

Takes steps to ensure enough stocks for Covid-19 management

US partially ends HCQ, CQ use for COVID-19

The EUA allows medication to treat an ailment on an emergency basis without a full authorisation for the specific disease for which other medicines are not available.

No survival benefit in Covid-19 patients receiving HCQ: Study

The researchers--from the Columbia VA Health Care System, the University of South Carolina, and the University of Virginia School of Medicine in the US--reported that their study has strengths that earlier studies have not had

Doing our best in Covid fight: Eatala

Says Centre guidelines being followed; doctors, healthcare workers risking their lives

WHO includes hydroxychloroquine in solidarity trial again

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said: "On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

Favipiravir-based coronavirus drug development speeds up

Industry working on combinational therapies and integrating capabilities across bulk drugs, intermediates and formulations to meet global demand

HCQ under spotlight again

While WHO announces temporary suspension of drug trials, ICMR recommends use for frontline workers

WHO suspends hydroxychloroquine clinical trial on COVID-19 patients

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalised.

Modi’s ‘self-reliance’ call need of the hour: Pharma Industry

The government had earlier come out with greater contours of active pharmaceutical ingredient (API) policy which is expected to increase self-reliance in fermentation-based API industry, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.

India sends 2 lakh hydroxychloroquine tablets, medical supplies to Myanmar

A release of Indian Embassy said the contribution is indicative of the traditionally warm and friendly ties between the two countries.

Hospitals in US using HCQ to treat Covid patients

HCQ is currently the first-line therapy in Yale. It's cheap and people are relatively comfortable with it- Nihar Desai, Indian-American cardiologist

Covid-19 positive patients with mild symptoms can now home-isolate themselves

 The Ministry of Health and Family Welfare is now allowing home-isolation for Covid-19 positive patients with mild symptoms.

TSPCB expedites permission process to manufacture HCQ

As a part of comprehensive system to handle the COVID-19 outbreak, GoI is permitting life saving drugs to control the outbreak COVID-19 and gave orders accordingly to State pollution control boards

Telangana says ‘no’ to self-medication

To discourage over-the-counter sale of drugs related to treatment of respiratory illness

Hydroxychloroquine may not be effective against COVID-19: Chinese study

According to the study appeared in the pre-print repository medRxiv which is yet to be peer-reviewed, the Chinese research team showed that hydroxychloroquine did not help patients clear the virus better than standard care.

COVID-19: HCQ efficacy lacks clinical evidence

Senior health officials made clear the need to have more data to understand whether the drug along with other drugs is efficient in treating Covid-19 cases

Consignment of hydroxychloroquine from India arrives at Newark airport

The number of people who have died in the United States from COVID-19 related complications has surpassed 20,000.

Social distancing only way to contain pandemic

A microorganism of 120 nanomicrons size made its entry into our world in December 2019 via Wuhan city, capital of China’s Hubei province and...

Trump thanks PM Modi for allowing export of Hydroxychloroquine

India manufactures 70 percent of the world's supply of Hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain.

India lifts Hydroxychloroquine export ban partially

India paves ways for supply to US, several other countries hit hard by coronavirus pandemic

Latest news

- Advertisement -spot_img
Telangana Today